Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

February 24, 2021
Preprint
Open Access

The Host Interactome of Spike Expands the Tropism of SARS-CoV-2.

BioRxiv : the Preprint Server for Biology
Casimir BambergerJohn Yates
February 18, 2021
Review
Open Access

mRNA vaccine: a potential therapeutic strategy.

Molecular Cancer
Yang WangXiawei Wei
February 13, 2021
Review
Open Access

Imaging Viral Infection by Fluorescence Microscopy: Focus on HIV-1 Early Stage.

Viruses
Soumajit MukherjeeHalina Anton
February 13, 2021
Open Access

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.

European Journal of Immunology
Bernard VanhoveJean-Paul Soulillou
February 10, 2021
Review
Open Access

Antibody-dependent enhancement of bacterial disease: Prevalence, mechanisms and treatment.

Infection and Immunity
Von Vergel L TorresTimothy J Wells
February 10, 2021
Open Access

Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.

Angewandte Chemie
Miao SunChaoyong Yang
February 4, 2021
Preprint
Open Access

Mechanism of Viral Glycoprotein Targeting by Membrane-associated-RING-CH Proteins.

BioRxiv : the Preprint Server for Biology
Cheng Man LunEric O Freed
February 4, 2021
Open Access

Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody.

Biochemical and Biophysical Research Communications
Sang Il KimJunho Chung
February 3, 2021
Preprint
Open Access

A cautionary note on recall vaccination in ex-COVID-19 subjects

MedRxiv : the Preprint Server for Health Sciences
R. LeviMaria Rescigno
February 2, 2021
Review
Open Access

Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.

Journal of Advanced Research
Zahra KhoshkamSasan Fereidouni
February 2, 2021
Open Access

Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2.

Nature
Annette B VogelUgur Sahin
January 28, 2021
Open Access

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.

Cell Reports
Huibin LvChris K P Mok
January 28, 2021

Use of 5-Thio-L-Fucose to modulate binding affinity of therapeutic proteins.

Biotechnology and Bioengineering
Martina ZimmermannAline Zimmer
January 27, 2021
Open Access

Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand.

Emerging Infectious Diseases
Panjaporn ChaichanaSusanna J Dunachie

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/antibody-dependent-enhancement/6a860370-862b-431f-b081-1bc5d499b117